Trump signs executive order to leave World Health Organization
The healthcare industry has shared its concerns on a global scale after President Trump signed the executive order.
The healthcare industry has shared its concerns on a global scale after President Trump signed the executive order.
Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao via Getty Images.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
JP Morgan 2025: Incyte expects period of ‘defining catalysts’
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
FDA CDER director Patrizia Cavazzoni announces resignation
Artificial intelligence and atopic dermatitis: A new era for disease management?